<DOC>
	<DOCNO>NCT02075671</DOCNO>
	<brief_summary>Rosacea chronic inflammatory disorder characterize severe flushing ( transient erythema ) , non-transient erythema , papule , pustule , telangiectasia . Topical therapy always effective treating symptom rosacea . Furthermore , rapid recurrence common follow use systemic antibiotic , result chronic use medication control disease . Although exact pathogenesis rosacea unknown , treatment condition investigate base similarity acne photodamaged skin . Case report show promising result rosacea patient treat methyl aminolevulinate photodynamic therapy ( MAL - PDT ) . Other case report observe significant improvement papule , pustule , erythema , flush follow 5 - aminolevulinic acid photodynamic therapy ( ALA-PDT ) treatment patient rosacea , role ALA-PDT treatment rosacea report . We design pilot study investigate efficacy ALA-PDT treat papulopustular rosacea . The objective study follow : Primary objective : 1 . To evaluate improvement inflammatory lesion ( papule , pustule , nodule ) , erythema , telangiectasia rosacea assess Investigator 's Global Assessment ( IGA ) . 2 . To evaluate improvement inflammatory lesion ( papule , pustule , nodule ) rosacea assessed Inflammatory Lesion Investigator 's Global Assessment ( ILIGA ) . Secondary objective : 3 . To evaluate improvement rosacea associate erythema assess Clinical Erythema Assessment ( CEA ) scale . 4 . To evaluate improvement inflammatory lesion ( papule , pustule , nodule ) rosacea measure difference inflammatory lesion count . 5 . To evaluate improvement rosacea assess Patient Overall Assessment Scale .</brief_summary>
	<brief_title>Photodynamic Therapy Papulopustular Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1 . Ages 1879 year 2 . Clinical diagnosis papulopustular rosacea base physician evaluation . Only patient 350 papule and/or pustule , CEA total score â‰¥ 5 , ( See Section 4.1.3 ) enrol . 3 . History fail least one conventional treatment rosacea ( metronidazole , sodium sulfacetamide , tetracycline , azelaic acid ) interest continuous treatment agent . 1 . &lt; 18 &gt; 79 year age 2 . Allergy 5 aminolevulinic acid ( ALA ) component vehicle 3 . Use topical acne rosacea treatment ( face ) within 2 week prior Visit 1 4 . Use systemic antibiotic within 1 month prior Visit 1 5 . Use topical retinoids ( face ) within 1 month prior Visit 1 6 . Use systemic retinoids , include isotretinoin , within 6 month prior Visit 1 . 7 . Use laser light base rosacea treatment ( face ) within 1 month prior Visit 1 8 . Cosmetic procedure ( e.g. , superficial chemical peel , exfoliation microdermabrasion face ) within 2 month prior Visit 1 9 . Use topical corticosteroid ( face ) 1 month prior Visit 1 10 . Use systemic corticosteroid 3 month prior Visit 1 11 . Known suspected history drug alcohol abuse within past 6 month determine medical record patient interview 12 . History adverse reaction light exposure 13 . History disorder porphyrin metabolism 14 . Scarring infection area treat 15 . Extensive facial hair would either impair blue light exposure interfere lesion evaluation 16 . Inability make study visit anticipate poor compliance 17 . Pregnant female nurse mother . Eligible woman reproductive age require negative urine pregnancy test screening . They also require least one reliable form effective birth control [ example : barrier method ( condom , diaphragm ) , oral , injectable , implant birth control abstinence ] course study 30 day follow last treatment period . 18 . Life threaten illness would interfere patient 's ability complete study 19 . Participation another clinical experimental therapeutic study within 30 day screen visit 20 . Any history evidence severe illness condition would make patient , opinion investigator , unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Rosacea</keyword>
	<keyword>Photodynamic Therapy</keyword>
	<keyword>Aminolevulinic Acid</keyword>
	<keyword>Papulopustular Rosacea</keyword>
	<keyword>Blue Light</keyword>
</DOC>